Chinese consider trial protocols for traditional meds

Drug experts in China are creating clinical trial protocols for traditional Chinese medicines in an attempt to hasten market acceptance. Traditional development yields customized treatments based on individual demands rather than the principles of modern medicine, posing a difficult match-up between Western drug approval standards and Eastern medicine development. But use of the so-called circular model of drug development, which contrasts with the regulated hierarchical model of the East, may help balance the two methods for a truer assessment of traditional Chinese medicine. Article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.